首页 > 最新文献

Digestive Endoscopy最新文献

英文 中文
Underwater Endoscopic Mucosal Resection With a Bipolar Snare for a Small Non-Ampullary Duodenal Neuroendocrine Tumor (With Video) 双极陷阱水下内镜粘膜切除术治疗非壶腹十二指肠小神经内分泌肿瘤(附视频)。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-23 DOI: 10.1111/den.70051
Mamoru Tokunaga, Yoshiyasu Kitagawa, Takuto Suzuki

Endoscopic resection is a treatment option for non-ampullary duodenal neuroendocrine tumors (DNETs) confined to the submucosa, without nodal or distant metastasis, and < 10 mm [1]. However, because the duodenal wall is thin and DNETs arise from the deep mucosa, endoscopic treatment carries risks of incomplete histopathological resection and adverse events (AEs)—notably perforation and bleeding [2]. Underwater endoscopic mucosal resection (UEMR) has recently been reported effective for superficial non-ampullary duodenal epithelial tumors (SNADETs) [3, 4]. Furthermore, Japanese prospective data indicate a favorable safety profile for UEMR in SNADETs [3]; in a multinational comparison, UEMR was associated with fewer AEs than conventional EMR (CEMR) [4]; and CEMR using a bipolar snare has been reported safe [5]. Accordingly, we considered UEMR with a bipolar snare a potentially effective, safety-oriented option for small non-ampullary DNETs. We present a 72-year-old man in whom an 8-mm submucosal DNET was resected by UEMR using a bipolar snare (Video S1). The lesion, on the inferior wall of the duodenal bulb, appeared subepithelial (Figure 1). Forceps biopsy showed a neuroendocrine tumor; endoscopic ultrasonography confirmed submucosal confinement, and computed tomography showed no nodal or distant metastasis. The procedure used a GIF-XZ1200 gastroscope and EVIS X1 system (Olympus, Tokyo, Japan). Resection was completed with a 13-mm bipolar snare (ZEMEX Bipolar Snare S, Zeon Medical Co. Ltd., Tokyo, Japan) and VIO 3 (ERBE Elektromedizin, Tübingen, Germany; Auto Cut mode, Effect 3). Procedure time was 3 min. There were no AEs, and histopathology showed a well-differentiated NET G1 (7 × 4 × 3 mm; pT1, Ly0, V1) with negative lateral and vertical margins (Figure 2). Subsequent distal gastrectomy revealed no residual tumor or nodal metastasis. Although DNET-specific UEMR data are limited, UEMR with a bipolar snare may be a safe and effective resection method for small non-ampullary DNETs, consistent with reports on duodenal adenomas (Video S1).

Mamoru Tokunaga: conceptualization; investigation; procedure; video editing; writing – original draft. Yoshiyasu Kitagawa: procedure; writing – review and editing; supervision. Takuto Suzuki: writing – review and editing; supervision. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.

The authors have nothing to report.

We confirm that informed consent has been obtained from the patient for the publication of their information and imaging data.

The authors declare no conflicts of interest.

内镜切除是非壶腹性十二指肠神经内分泌肿瘤(DNETs)局限于粘膜下层,无淋巴结或远处转移,且直径≤10 mm的治疗选择。然而,由于十二指肠壁较薄,DNETs起源于深部粘膜,内镜治疗存在组织病理学切除不完全和不良事件(ae)的风险,尤其是穿孔和出血。水下内镜粘膜切除术(UEMR)最近被报道对浅表非壶腹性十二指肠上皮肿瘤(SNADETs)有效[3,4]。此外,日本的前瞻性数据表明,UEMR在snadet患者中具有良好的安全性。在一项跨国比较中,与传统EMR (CEMR)相比,UEMR与更少的ae相关;使用双极诱捕器的CEMR已被报道为安全的[5]。因此,我们认为带双极陷阱的UEMR可能是小型非壶腹性DNETs的有效且安全的选择。我们报告了一位72岁的男性患者,他使用双极陷阱通过UEMR切除了8mm的粘膜下DNET(视频S1)。病变位于十二指肠球的下壁,位于上皮下(图1)。钳活检显示神经内分泌肿瘤;超声内镜证实粘膜下封闭,计算机断层扫描未见淋巴结或远处转移。手术使用GIF-XZ1200胃镜和EVIS X1系统(Olympus, Tokyo, Japan)。切除使用13毫米双极陷阱(ZEMEX双极陷阱S, Zeon Medical Co. Ltd, Tokyo, Japan)和VIO 3 (ERBE Elektromedizin, t宾根,Germany; Auto Cut mode, Effect 3)完成。手术时间3 min。无ae,组织病理学显示分化良好的NET G1 (7 × 4 × 3 mm; pT1, Ly0, V1),侧缘和垂直缘为阴性(图2)。随后的远端胃切除术未发现肿瘤残留或淋巴结转移。虽然dnet特异性的UEMR数据有限,但与十二指肠腺瘤的报道一致,双极陷阱的UEMR可能是一种安全有效的小的非壶腹DNETs切除方法。德永守:概念化;调查;程序;视频编辑;写作-原稿。北川义康:程序;写作——审阅和编辑;监督。铃木拓人:写作-评论和编辑;监督。所有作者阅读并批准最终稿件,并同意对工作的各个方面负责。作者没有什么可报告的。我们确认已获得患者的知情同意,以公布其信息和成像数据。作者声明无利益冲突。
{"title":"Underwater Endoscopic Mucosal Resection With a Bipolar Snare for a Small Non-Ampullary Duodenal Neuroendocrine Tumor (With Video)","authors":"Mamoru Tokunaga,&nbsp;Yoshiyasu Kitagawa,&nbsp;Takuto Suzuki","doi":"10.1111/den.70051","DOIUrl":"10.1111/den.70051","url":null,"abstract":"<p>Endoscopic resection is a treatment option for non-ampullary duodenal neuroendocrine tumors (DNETs) confined to the submucosa, without nodal or distant metastasis, and &lt; 10 mm [<span>1</span>]. However, because the duodenal wall is thin and DNETs arise from the deep mucosa, endoscopic treatment carries risks of incomplete histopathological resection and adverse events (AEs)—notably perforation and bleeding [<span>2</span>]. Underwater endoscopic mucosal resection (UEMR) has recently been reported effective for superficial non-ampullary duodenal epithelial tumors (SNADETs) [<span>3, 4</span>]. Furthermore, Japanese prospective data indicate a favorable safety profile for UEMR in SNADETs [<span>3</span>]; in a multinational comparison, UEMR was associated with fewer AEs than conventional EMR (CEMR) [<span>4</span>]; and CEMR using a bipolar snare has been reported safe [<span>5</span>]. Accordingly, we considered UEMR with a bipolar snare a potentially effective, safety-oriented option for small non-ampullary DNETs. We present a 72-year-old man in whom an 8-mm submucosal DNET was resected by UEMR using a bipolar snare (Video S1). The lesion, on the inferior wall of the duodenal bulb, appeared subepithelial (Figure 1). Forceps biopsy showed a neuroendocrine tumor; endoscopic ultrasonography confirmed submucosal confinement, and computed tomography showed no nodal or distant metastasis. The procedure used a GIF-XZ1200 gastroscope and EVIS X1 system (Olympus, Tokyo, Japan). Resection was completed with a 13-mm bipolar snare (ZEMEX Bipolar Snare S, Zeon Medical Co. Ltd., Tokyo, Japan) and VIO 3 (ERBE Elektromedizin, Tübingen, Germany; Auto Cut mode, Effect 3). Procedure time was 3 min. There were no AEs, and histopathology showed a well-differentiated NET G1 (7 × 4 × 3 mm; pT1, Ly0, V1) with negative lateral and vertical margins (Figure 2). Subsequent distal gastrectomy revealed no residual tumor or nodal metastasis. Although DNET-specific UEMR data are limited, UEMR with a bipolar snare may be a safe and effective resection method for small non-ampullary DNETs, consistent with reports on duodenal adenomas (Video S1).</p><p><b>Mamoru Tokunaga:</b> conceptualization; investigation; procedure; video editing; writing – original draft. <b>Yoshiyasu Kitagawa:</b> procedure; writing – review and editing; supervision. <b>Takuto Suzuki:</b> writing – review and editing; supervision. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.</p><p>The authors have nothing to report.</p><p>We confirm that informed consent has been obtained from the patient for the publication of their information and imaging data.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70051","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Evaluation of Percutaneous Transhepatic Biliary Drainage and Endoscopic Ultrasound-Guided Biliary Drainage for Preoperative Management of Malignant Distal Bile Duct Obstruction After Failed ERCP: A Multicenter Retrospective Analysis 经皮经肝胆道引流与超声内镜引导下胆道引流在ERCP失败后恶性胆管远端梗阻术前的比较评价:一项多中心回顾性分析。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-22 DOI: 10.1111/den.70048
Masahiro Itonaga, Mamoru Takenaka, Hideyuki Shiomi, Koh Kitagawa, Shuhei Shintani, Hirotsugu Maruyama, Ryota Sagami, Tsukasa Ikeura, Takeshi Ogura, Yusuke Ishida, Koichiro Mandai, Satoshi Sugimori, Yoshiki Imamura, Atsuhiro Masuda, Kenji Ikezawa, Atsushi Shimizu, Atsushi Nakai, Minako Nagai, Ryota Nakano, Ke Wan, Toshio Shimokawa, Masayuki Kitano

Objectives

This multicenter retrospective study aimed to compare surgery-related adverse events (AEs) of percutaneous transhepatic biliary drainage (PTBD) with those of endoscopic ultrasound-guided biliary drainage (EUS-BD) for preoperative management of malignant distal bile duct obstruction (MDBO).

Methods

We reviewed data from 15 centers in Japan between 2012 and 2021. Patients with MDBO who underwent PTBD or EUS-BD after failed endoscopic retrograde cholangiopancreatography (ERCP) and later underwent pancreaticoduodenectomy (PD) were included. The primary outcome was surgery-related AEs. Secondary outcomes included drainage-related outcomes, surgery-related outcomes, disease-free survival (DFS), and overall survival (OS). Risk factors associated with surgery-related AEs were also evaluated.

Results

In total, 2350 patients received biliary drainage before PD. Of the 73 patients in whom ERCP failed, 65 underwent PTBD and 11 underwent EUS-BD. EUS-BD showed a significantly higher internalization rate (100% vs. 28%, p < 0.001), fewer sessions (median 1 vs. 2, p = 0.006), and shorter hospital stay (10 vs. 22 days, p = 0.002). Surgery-related AEs were similar between groups. In the multivariate analysis, age ≥ 71 years and ASA-PS ≥ 2 were identified as significant risk factors for surgery-related AEs, whereas the drainage method was not a significant factor. No significant differences were observed in DFS or OS between the groups.

Conclusions

Surgical-related outcomes, DFS, and OS after EUS-BD were comparable to those after PTBD; however, EUS-BD allowed a higher internalization rate, fewer sessions, and a shorter hospital stay, making it the preferred option for preoperative biliary drainage after failed ERCP.

目的:本多中心回顾性研究旨在比较经皮经肝胆道引流术(PTBD)与超声内镜引导胆道引流术(EUS-BD)在恶性胆管远端梗阻(MDBO)术前治疗中的手术相关不良事件(ae)。方法:我们回顾了2012年至2021年间日本15个中心的数据。包括内镜逆行胆管造影(ERCP)失败后行PTBD或EUS-BD的MDBO患者,后来行胰十二指肠切除术(PD)。主要结局是手术相关的不良事件。次要结局包括引流相关结局、手术相关结局、无病生存期(DFS)和总生存期(OS)。与手术相关不良事件相关的危险因素也进行了评估。结果:共有2350例患者在PD前接受了胆道引流。在ERCP失败的73例患者中,65例接受了PTBD, 11例接受了EUS-BD。结论:EUS-BD术后的手术相关结果、DFS和OS与PTBD术后相当;然而,EUS-BD的内化率更高,疗程更少,住院时间更短,使其成为ERCP失败后术前胆道引流的首选。
{"title":"Comparative Evaluation of Percutaneous Transhepatic Biliary Drainage and Endoscopic Ultrasound-Guided Biliary Drainage for Preoperative Management of Malignant Distal Bile Duct Obstruction After Failed ERCP: A Multicenter Retrospective Analysis","authors":"Masahiro Itonaga,&nbsp;Mamoru Takenaka,&nbsp;Hideyuki Shiomi,&nbsp;Koh Kitagawa,&nbsp;Shuhei Shintani,&nbsp;Hirotsugu Maruyama,&nbsp;Ryota Sagami,&nbsp;Tsukasa Ikeura,&nbsp;Takeshi Ogura,&nbsp;Yusuke Ishida,&nbsp;Koichiro Mandai,&nbsp;Satoshi Sugimori,&nbsp;Yoshiki Imamura,&nbsp;Atsuhiro Masuda,&nbsp;Kenji Ikezawa,&nbsp;Atsushi Shimizu,&nbsp;Atsushi Nakai,&nbsp;Minako Nagai,&nbsp;Ryota Nakano,&nbsp;Ke Wan,&nbsp;Toshio Shimokawa,&nbsp;Masayuki Kitano","doi":"10.1111/den.70048","DOIUrl":"10.1111/den.70048","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This multicenter retrospective study aimed to compare surgery-related adverse events (AEs) of percutaneous transhepatic biliary drainage (PTBD) with those of endoscopic ultrasound-guided biliary drainage (EUS-BD) for preoperative management of malignant distal bile duct obstruction (MDBO).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We reviewed data from 15 centers in Japan between 2012 and 2021. Patients with MDBO who underwent PTBD or EUS-BD after failed endoscopic retrograde cholangiopancreatography (ERCP) and later underwent pancreaticoduodenectomy (PD) were included. The primary outcome was surgery-related AEs. Secondary outcomes included drainage-related outcomes, surgery-related outcomes, disease-free survival (DFS), and overall survival (OS). Risk factors associated with surgery-related AEs were also evaluated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total, 2350 patients received biliary drainage before PD. Of the 73 patients in whom ERCP failed, 65 underwent PTBD and 11 underwent EUS-BD. EUS-BD showed a significantly higher internalization rate (100% vs. 28%, <i>p</i> &lt; 0.001), fewer sessions (median 1 vs. 2, <i>p</i> = 0.006), and shorter hospital stay (10 vs. 22 days, <i>p</i> = 0.002). Surgery-related AEs were similar between groups. In the multivariate analysis, age ≥ 71 years and ASA-PS ≥ 2 were identified as significant risk factors for surgery-related AEs, whereas the drainage method was not a significant factor. No significant differences were observed in DFS or OS between the groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Surgical-related outcomes, DFS, and OS after EUS-BD were comparable to those after PTBD; however, EUS-BD allowed a higher internalization rate, fewer sessions, and a shorter hospital stay, making it the preferred option for preoperative biliary drainage after failed ERCP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Approach to Predict Metastatic Recurrence Risk After Endoscopic Resection for Esophageal Squamous Cell Carcinoma 食管鳞状细胞癌内镜切除后转移复发风险的回顾性预测。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-21 DOI: 10.1111/den.70050
Toshiyuki Yoshio
<p>Recent progress in early detection of esophageal squamous cell carcinoma (ESCC) has led to the widespread acceptance of endoscopic submucosal dissection (ESD) as a minimally invasive treatment. Advances in ESD techniques and the implementation of preventive measures for post-ESD strictures—such as local triamcinolone injections—have yielded favorable outcomes [<span>1</span>], contributing to the expansion of ESD indications to larger and more advanced lesions. We are in the process of expanding complete circumferential resection to larger ESCC [<span>2</span>]. Treatment strategies are typically determined based on preoperative assessment of invasion depth. When preoperative diagnosis is cT1a-epithelium (EP)/lamina propria mucosae (LPM), endoscopic resection (ER) is generally indicated [<span>1</span>]. Even in cases diagnosed as cT1a-mascularis mucosae (MM) or cT1b-submucosa (SM) 1, observation following ER is feasible in a substantial proportion of cases [<span>3</span>], leading to the broad adoption of ESD, which facilitates reliable en-bloc resection for lesions requiring precise histological evaluation. Limitation of preoperative invasion diagnosis is also the reason to facilitate the use of ESD. The diagnostic accuracy of ME-NBI using B2 vessels for cT1a–MM and cT1b–SM1 lesions remains modest (55.7%) [<span>1</span>], emphasizing the importance of pathological evaluation after ER.</p><p>When postoperative pathological assessment reveals pT1a-EP/LPM/MM without lymphovascular invasion (LVI), favorable clinical outcomes have been reported without additional therapy [<span>1, 3-7</span>]. However, in cases with submucosal invasion or LVI, the risk of metastasis or recurrence is considered high, and additional treatment is generally recommended. Consequently, esophagectomy or chemoradiation therapy (CRT) is commonly performed, both of which have demonstrated favorable clinical outcomes [<span>8</span>]. Nevertheless, accurate data regarding the rate of metastasis or recurrence in patients who do not receive additional treatment remain lacking.</p><p>Treatment strategies have previously been guided by lymph node (LN) metastasis rates based on the depth of invasion diagnosed in surgical pathology specimens and the evaluation of metastasis in dissected LNs during esophagectomy. However, surgical specimens are typically sectioned at 5-mm intervals, whereas ER specimens are processed at 2-mm intervals. This discrepancy in tissue processing leads to a potential underestimation of invasion depth in surgical cases, resulting in an overestimation of metastasis risk. For instance, the reported LN metastasis rate for pT1a-MM lesions in surgical cases was 14.6% (95% CI: 10.0–20.3), whereas ER cases show a considerably lower rate of 5.6% (95% CI: 2.9–9.5) [<span>1</span>]. These differences have gradually become more apparent, and the metastasis rate based on ER specimens has emerged as a necessary metric for clinical decision-making.</p><p>What is the
近年来在食管鳞状细胞癌(ESCC)早期检测方面的进展使得内镜下粘膜剥离(ESD)作为一种微创治疗方法被广泛接受。ESD技术的进步和ESD后狭窄预防措施的实施(如局部注射曲安奈德)已经产生了良好的结果,有助于将ESD适应症扩展到更大、更晚期的病变。我们正在对更大的ESCC进行全周切除。治疗策略通常是根据术前对侵袭深度的评估来确定的。当术前诊断为ct1a -上皮(EP)/固有层粘膜(LPM)时,内镜下切除(ER)一般指[1]。即使在诊断为ct1 -男性粘膜炎(MM)或ct1b -粘膜下层(SM) 1的病例中,也有相当比例的病例b[3]可以在ER后进行观察,因此广泛采用ESD,这有助于对需要精确组织学评估的病变进行可靠的整体切除。术前侵犯诊断的局限性也是ESD应用不便的原因。使用B2血管对cT1a-MM和cT1b-SM1病变的ME-NBI诊断准确率仍然不高(55.7%),强调ER后病理评估的重要性。当术后病理评估显示pT1a-EP/LPM/MM无淋巴血管侵犯(LVI)时,临床结果良好,无需额外治疗[1,3 -7]。然而,在粘膜下浸润或LVI的情况下,转移或复发的风险被认为是高的,通常建议额外的治疗。因此,通常进行食管切除术或放化疗(CRT),这两种方法均显示出良好的临床效果[10]。然而,关于未接受额外治疗的患者的转移率或复发率的准确数据仍然缺乏。治疗策略以前是根据手术病理标本中诊断的淋巴结(LN)转移率和食管切除术中解剖淋巴结转移的评估来指导的。然而,手术标本通常以5毫米的间隔切片,而急诊标本以2毫米的间隔处理。这种组织处理的差异导致手术病例中潜在的对侵袭深度的低估,从而导致对转移风险的高估。例如,据报道,手术病例中pt1 - mm病变的淋巴结转移率为14.6% (95% CI: 10.0-20.3),而ER病例的转移率则低得多,为5.6% (95% CI: 2.9-9.5)。这些差异逐渐变得更加明显,基于ER标本的转移率已成为临床决策的必要指标。对于pT1b-SM1/SM2或pT1a-MM合并LVI的患者,ER后的预期转移风险是什么?这些病例通常需要额外的治疗,因此,仅观察转移率的数据是非常有限的。不接受进一步治疗的患者通常由于高龄或合并症而受到限制,这使得长期累积转移率难以评估。单中心研究往往病例数不足,多中心研究在一致的数据汇总方面面临挑战。然而,当遇到考虑观察而不进行额外治疗的患者时,评估转移风险成为关键问题。澄清这一风险也有助于评估CRT或食管切除术的附加效果。几项回顾性研究[5-8]报道了未接受额外治疗的病例,虽然每项研究都提供了丰富的信息,但不同侵袭深度和LVI状态的转移风险仍未得到充分阐明。在本期的《消化道内窥镜》杂志上,Ishihara等人报道了ESCC患者在ESD后接受额外食管切除术,病理表现为粘膜下浸润或LVI的转移率。值得注意的是,术后5年生存率为92.3%。这种分析方法特别可靠,因为侵入深度和LVI的存在是基于间隔2毫米的ER标本切片来评估的。因此,可以评估手术切除时淋巴结转移的频率和术后转移率。在本报告中,根据浸润深度,LVI的存在和垂直边缘(VM)的状态计算转移率。正如预期的那样,发生率明显低于先前手术病例的报道,可能反映了标本切片方法的差异。例如,在这项研究中,pT1b病变的转移率报道为16.3%,明显低于先前发表的pSM1的转移率25.3% (95% CI: 19.0-32.5)和25.0% (95% CI: 19)。 1 - 31.7)为pSM2[1]。与先前的研究结果一致,LVI仍然是转移的强预测因素;然而,SM1和SM2之间的转移频率差异很小。具体来说,没有LVI的SM1和SM2病变的转移率分别为8.0%和9.4%,而有LVI的MM为25.7%,SM1为32.3%,SM2为27.7%。VM1或VMX患者的转移率为35.1%,局部残留率为19.2%,这也是令人震惊的发现。目前,本研究报告的转移复发率被认为是预测ER后粘膜下浸润或LVI的ESCC患者预后的最可靠指标,并进行观察管理。这些数据在由于高龄、合并症或患者偏好而不进行额外食管切除术或CRT的病例中特别有价值。值得注意的是,据报道,食管切除术和CRT的治疗相关死亡率分别为1.9%和1.7%,这强调了个体化风险-收益评估的重要性。将这些病理危险因素与患者特异性预后指标(如年龄、性别、Charlson合并症指数和预后营养指数)结合起来,可以对治疗方案进行更实际的评估。他们为评估额外治疗的风险和益处提供了关键的支持。通过利用这些发现,临床医生可以为患者提供知情的解释,促进共同决策和选择最佳治疗策略。作者声明无利益冲突。食管癌内镜下粘膜下非治愈性剥离术后转移和局部残留癌的风险,http://doi.org/10.1111/den.15082。
{"title":"A Retrospective Approach to Predict Metastatic Recurrence Risk After Endoscopic Resection for Esophageal Squamous Cell Carcinoma","authors":"Toshiyuki Yoshio","doi":"10.1111/den.70050","DOIUrl":"10.1111/den.70050","url":null,"abstract":"&lt;p&gt;Recent progress in early detection of esophageal squamous cell carcinoma (ESCC) has led to the widespread acceptance of endoscopic submucosal dissection (ESD) as a minimally invasive treatment. Advances in ESD techniques and the implementation of preventive measures for post-ESD strictures—such as local triamcinolone injections—have yielded favorable outcomes [&lt;span&gt;1&lt;/span&gt;], contributing to the expansion of ESD indications to larger and more advanced lesions. We are in the process of expanding complete circumferential resection to larger ESCC [&lt;span&gt;2&lt;/span&gt;]. Treatment strategies are typically determined based on preoperative assessment of invasion depth. When preoperative diagnosis is cT1a-epithelium (EP)/lamina propria mucosae (LPM), endoscopic resection (ER) is generally indicated [&lt;span&gt;1&lt;/span&gt;]. Even in cases diagnosed as cT1a-mascularis mucosae (MM) or cT1b-submucosa (SM) 1, observation following ER is feasible in a substantial proportion of cases [&lt;span&gt;3&lt;/span&gt;], leading to the broad adoption of ESD, which facilitates reliable en-bloc resection for lesions requiring precise histological evaluation. Limitation of preoperative invasion diagnosis is also the reason to facilitate the use of ESD. The diagnostic accuracy of ME-NBI using B2 vessels for cT1a–MM and cT1b–SM1 lesions remains modest (55.7%) [&lt;span&gt;1&lt;/span&gt;], emphasizing the importance of pathological evaluation after ER.&lt;/p&gt;&lt;p&gt;When postoperative pathological assessment reveals pT1a-EP/LPM/MM without lymphovascular invasion (LVI), favorable clinical outcomes have been reported without additional therapy [&lt;span&gt;1, 3-7&lt;/span&gt;]. However, in cases with submucosal invasion or LVI, the risk of metastasis or recurrence is considered high, and additional treatment is generally recommended. Consequently, esophagectomy or chemoradiation therapy (CRT) is commonly performed, both of which have demonstrated favorable clinical outcomes [&lt;span&gt;8&lt;/span&gt;]. Nevertheless, accurate data regarding the rate of metastasis or recurrence in patients who do not receive additional treatment remain lacking.&lt;/p&gt;&lt;p&gt;Treatment strategies have previously been guided by lymph node (LN) metastasis rates based on the depth of invasion diagnosed in surgical pathology specimens and the evaluation of metastasis in dissected LNs during esophagectomy. However, surgical specimens are typically sectioned at 5-mm intervals, whereas ER specimens are processed at 2-mm intervals. This discrepancy in tissue processing leads to a potential underestimation of invasion depth in surgical cases, resulting in an overestimation of metastasis risk. For instance, the reported LN metastasis rate for pT1a-MM lesions in surgical cases was 14.6% (95% CI: 10.0–20.3), whereas ER cases show a considerably lower rate of 5.6% (95% CI: 2.9–9.5) [&lt;span&gt;1&lt;/span&gt;]. These differences have gradually become more apparent, and the metastasis rate based on ER specimens has emerged as a necessary metric for clinical decision-making.&lt;/p&gt;&lt;p&gt;What is the ","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145338197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Plastic Stent With an Integrated Delivery System for Endoscopic Transpapillary Gallbladder Stenting: A Preliminary Feasibility Study (With Video) 新型塑料支架集成输送系统用于内镜下经乳头胆囊支架植入:初步可行性研究(附视频)。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-21 DOI: 10.1111/den.70053
Kazunari Nakahara, Takao Itoi, Junya Sato, Yosuke Igarashi, Yusuke Satta, Akihiro Sekine, Haruka Niwa, Yu Matsuda, Shintaro Kamimukai, Shinjiro Kobayashi, Keisuke Tateishi

A novel plastic stent with an integrated delivery system specifically designed for endoscopic transpapillary gallbladder stenting (EGBS) was developed. The novel stent system comprises a stent body, an inner catheter, and a pushing catheter. The stent and pusher catheter are integrated, thereby making it possible to pull back the stent. Further, it fits the anatomical shape after placement in the gallbladder as it has a curved shape. The current study evaluated the feasibility and outcomes of EGBS using the novel stent. This retrospective study analyzed the clinical data of 24 consecutive patients who underwent EGBS using the novel stent between April 2023 and March 2025. The technical success rate of stent insertion was 95.8%. In the technically successful EGBS cases, the clinical success rate for acute cholecystitis was 94.7%. The early adverse event (AE) rate was 4.2%, with only one patient presenting with Mallory–Weiss syndrome. During a mean follow-up period of 211 days, the late AE rate in the 20 patients with permanent stent placement was 10%. The late AEs included acute pancreatitis (n = 1) and gallbladder perforation (n = 1). Acute pancreatitis improved with stent removal, and gallbladder perforation resolved with additional percutaneous transhepatic gallbladder drainage. There were no cases of recurrent cholecystitis or stent migration during the follow-up period. In conclusion, the newly developed stent is feasible for EGBS and can achieve good clinical outcomes.

为内镜下经乳头胆囊支架植入(EGBS)设计了一种新型塑料支架及其集成输送系统。该新型支架系统包括支架本体、内导管和推导管。支架和推导管是一体的,因此可以将支架拉回。此外,它具有弯曲的形状,适合放置在胆囊后的解剖形状。目前的研究评估了使用这种新型支架的EGBS的可行性和结果。本回顾性研究分析了2023年4月至2025年3月连续24例使用新型支架接受EGBS的患者的临床资料。支架置入技术成功率为95.8%。在技术上成功的EGBS病例中,急性胆囊炎的临床成功率为94.7%。早期不良事件(AE)发生率为4.2%,仅有1例患者出现Mallory-Weiss综合征。在平均211天的随访期间,20例永久性支架置入患者的晚期AE发生率为10%。晚期ae包括急性胰腺炎(n = 1)和胆囊穿孔(n = 1)。急性胰腺炎在支架移除后得到改善,胆囊穿孔通过额外的经皮经肝胆囊引流得到解决。随访期间无胆囊炎复发或支架移位病例。综上所述,新开发的支架用于EGBS是可行的,可以取得良好的临床效果。
{"title":"Novel Plastic Stent With an Integrated Delivery System for Endoscopic Transpapillary Gallbladder Stenting: A Preliminary Feasibility Study (With Video)","authors":"Kazunari Nakahara,&nbsp;Takao Itoi,&nbsp;Junya Sato,&nbsp;Yosuke Igarashi,&nbsp;Yusuke Satta,&nbsp;Akihiro Sekine,&nbsp;Haruka Niwa,&nbsp;Yu Matsuda,&nbsp;Shintaro Kamimukai,&nbsp;Shinjiro Kobayashi,&nbsp;Keisuke Tateishi","doi":"10.1111/den.70053","DOIUrl":"10.1111/den.70053","url":null,"abstract":"<div>\u0000 \u0000 <p>A novel plastic stent with an integrated delivery system specifically designed for endoscopic transpapillary gallbladder stenting (EGBS) was developed. The novel stent system comprises a stent body, an inner catheter, and a pushing catheter. The stent and pusher catheter are integrated, thereby making it possible to pull back the stent. Further, it fits the anatomical shape after placement in the gallbladder as it has a curved shape. The current study evaluated the feasibility and outcomes of EGBS using the novel stent. This retrospective study analyzed the clinical data of 24 consecutive patients who underwent EGBS using the novel stent between April 2023 and March 2025. The technical success rate of stent insertion was 95.8%. In the technically successful EGBS cases, the clinical success rate for acute cholecystitis was 94.7%. The early adverse event (AE) rate was 4.2%, with only one patient presenting with Mallory–Weiss syndrome. During a mean follow-up period of 211 days, the late AE rate in the 20 patients with permanent stent placement was 10%. The late AEs included acute pancreatitis (<i>n</i> = 1) and gallbladder perforation (<i>n</i> = 1). Acute pancreatitis improved with stent removal, and gallbladder perforation resolved with additional percutaneous transhepatic gallbladder drainage. There were no cases of recurrent cholecystitis or stent migration during the follow-up period. In conclusion, the newly developed stent is feasible for EGBS and can achieve good clinical outcomes.</p>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145338164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracheo-Esophageal Fistula Closure Using an “ESD-Flap” 使用“esd皮瓣”关闭气管-食管瘘。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-18 DOI: 10.1111/den.70049
Amani Beshara, Dorian Carpentier, Arnaud Lemmers

Endoscopic treatment of tracheoesophageal fistulas (TEFs) remains challenging. Conventional techniques, such as stenting, clips, macroclips, and fibrin glue, have shown limited success, with closure rates below 50%. Cardiac septal occluders have shown more promising results, with reported success rates of up to 77.7% [1]. Endoscopic submucosal dissection (ESD)–based flap closure has emerged as a novel approach, demonstrating > 80% success in limited case reports. Variations include (a) total fistulectomy before mechanical closure [2], (b) use of a traction line for flap manipulation [3], (c) closure with endoloop and clips [4], and (d) pedicle or free mucosal flap transplantation [5].

We treated a 38-year-old male with a history of type C esophageal atresia, early repaired surgically in infancy. His postoperative course had been complicated by esophageal stricture, managed with balloon dilatations. He was referred for evaluation of worsening cough and recurrent respiratory infections. A barium swallow revealed a short tracheobronchial fistula (Figure 1a). Under general anesthesia, we performed an ESD-based closure. Gastroscopy revealed a 5 mm fistula orifice at 20 cm from the dental arches, 2 cm above the esophago-esophageal anastomosis (Figure 1b). Following submucosal lifting with glycerol, a circumferential incision was made 1 cm from the fistula using a 1.5 mm dual knife. An apple-core-shaped flap was created, dissecting close to the muscularis propria, 5 mm from the fistula. Argon plasma coagulation was applied to ablate neoepithelium. The flap was grasped with an endoloop and secured with four clips to ensure healing, two Olympus EZ clips 7 mm and two Lockado 16 mm (Figure 2a,b). No contrast extravasation was observed postprocedure (Figure 2c, Video S1).

The patient showed rapid clinical improvement, with resolution of cough and aspiration. He received peri and postprocedural antibiotics for 5 days. A 6-week follow-up barium swallow showed no residual fistula (Figure 2d). He remained symptom-free during 2 years of follow-up.

All authors substantially contributed to the concept and the design of the work, drafting, reviewing, and finally approved the version to be published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

The authors declare no conflicts of interest.

内镜下治疗气管食管瘘(TEFs)仍然具有挑战性。传统的技术,如支架置入、夹子、大夹子和纤维蛋白胶,成功率有限,缝合率低于50%。心间隔封堵器显示出更有希望的结果,据报道成功率高达77.7%。内镜下粘膜剥离(ESD)为基础的皮瓣关闭已经成为一种新的方法,在有限的病例报告中显示80%的成功率。变化包括(a)机械闭合前全瘘切除术[2],(b)使用牵引线进行皮瓣操作[3],(c)用内环和夹子闭合[4],(d)带蒂或游离粘膜瓣移植[5]。我们治疗了一位38岁男性,有C型食管闭锁病史,在婴儿期早期手术修复。他的术后过程因食管狭窄而复杂化,用球囊扩张治疗。他被转介评估咳嗽恶化和反复呼吸道感染。钡餐检查显示短气管支气管瘘(图1a)。在全身麻醉下,我们进行了基于静电放电的缝合术。胃镜检查显示,在距牙弓20厘米处,食管-食管吻合口上方2厘米处,有一个5毫米的瘘口(图1b)。在用甘油提起粘膜下后,使用1.5 mm的双刀在距瘘管1cm处做一个圆周切口。创建一个苹果核状皮瓣,靠近固有肌层,离瘘管5mm。氩等离子凝固消融新上皮。皮瓣用内环抓住,用四个夹子固定以确保愈合,两个奥林巴斯EZ夹子7毫米,两个Lockado 16毫米(图2a,b)。术后未见造影剂外渗(图2c,视频S1)。患者临床症状迅速改善,咳嗽和误吸消失。术中及术后给予5天抗生素治疗。随访6周的钡餐检查未发现残留瘘管(图2d)。随访2年,患者无症状。所有作者都对本书的概念和设计做出了重大贡献,起草、审查并最终批准了即将出版的版本。所有作者同意对工作的各个方面负责,以确保与工作任何部分的准确性或完整性相关的问题得到适当的调查和解决。作者声明无利益冲突。
{"title":"Tracheo-Esophageal Fistula Closure Using an “ESD-Flap”","authors":"Amani Beshara,&nbsp;Dorian Carpentier,&nbsp;Arnaud Lemmers","doi":"10.1111/den.70049","DOIUrl":"10.1111/den.70049","url":null,"abstract":"<p>Endoscopic treatment of tracheoesophageal fistulas (TEFs) remains challenging. Conventional techniques, such as stenting, clips, macroclips, and fibrin glue, have shown limited success, with closure rates below 50%. Cardiac septal occluders have shown more promising results, with reported success rates of up to 77.7% [<span>1</span>]. Endoscopic submucosal dissection (ESD)–based flap closure has emerged as a novel approach, demonstrating &gt; 80% success in limited case reports. Variations include (a) total fistulectomy before mechanical closure [<span>2</span>], (b) use of a traction line for flap manipulation [<span>3</span>], (c) closure with endoloop and clips [<span>4</span>], and (d) pedicle or free mucosal flap transplantation [<span>5</span>].</p><p>We treated a 38-year-old male with a history of type C esophageal atresia, early repaired surgically in infancy. His postoperative course had been complicated by esophageal stricture, managed with balloon dilatations. He was referred for evaluation of worsening cough and recurrent respiratory infections. A barium swallow revealed a short tracheobronchial fistula (Figure 1a). Under general anesthesia, we performed an ESD-based closure. Gastroscopy revealed a 5 mm fistula orifice at 20 cm from the dental arches, 2 cm above the esophago-esophageal anastomosis (Figure 1b). Following submucosal lifting with glycerol, a circumferential incision was made 1 cm from the fistula using a 1.5 mm dual knife. An apple-core-shaped flap was created, dissecting close to the muscularis propria, 5 mm from the fistula. Argon plasma coagulation was applied to ablate neoepithelium. The flap was grasped with an endoloop and secured with four clips to ensure healing, two Olympus EZ clips 7 mm and two Lockado 16 mm (Figure 2a,b). No contrast extravasation was observed postprocedure (Figure 2c, Video S1).</p><p>The patient showed rapid clinical improvement, with resolution of cough and aspiration. He received peri and postprocedural antibiotics for 5 days. A 6-week follow-up barium swallow showed no residual fistula (Figure 2d). He remained symptom-free during 2 years of follow-up.</p><p>All authors substantially contributed to the concept and the design of the work, drafting, reviewing, and finally approved the version to be published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145314121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Submucosal Dissection of a Superficial Esophageal Neoplasm by 4-Point Inner-Traction Method 内镜下4点内牵引法剥离食管浅表肿瘤一例。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-17 DOI: 10.1111/den.70045
Jia Xu, Yang Liao, Xiaowei Tang

Endoscopic submucosal dissection (ESD) is a well-established technique for esophageal tumor removal. However, ESD remains challenging due to factors like thin submucosa, esophageal motility, and limited maneuverability. Additionally, a single endoscope cannot simultaneously perform the traction, prompting the development of novel traction techniques to reduce surgical risks and en-bloc resection rates [1-4]. In this case, we developed a new 4-point internal traction method (Video S1).

A 60-year-old man with superficial esophageal neoplasm underwent ESD. A dual knife was used to mark a 0.5-cm margin along the lesion's outer edge, followed by injection of a methylene blue hyaluronate sodium saline solution into the submucosa to lift the lesion. Mucosa and submucosa were dissected along markings. A rubber band was attached to the first endoclip, and a cotton thread was secured to the rubber band. The endoclip and cotton thread were fixed on the anal side of the lesion, with the other end of the cotton thread left outside to control the rubber band and subsequent endoclip placements. External traction with the rubber band allowed placement of the second endoclip across it, followed by securing the third and fourth endoclips. The rubber band retraction caused the lesion's edges to curl upwards and inwards, fully exposing the submucosa (Figure 1). With repeated submucosal injections, the lesion was completely dissected. The 3.2 × 2.8 × 0.3 cm lesion was entirely removed in about 35 min, and the patient experienced a favorable prognosis. The operation schematic is shown in Figure 2.

The 4-point traction method facilitates ESD, especially for larger lesions where conventional traction fails. Although more clips are used, procedure time is significantly reduced, improving safety and efficiency despite slightly higher material cost. The fixed elasticity of the rubber band makes this method ideal for lesions approximately 2–4 cm.

X.T.: conceptualization, methodology, writing – review and editing, supervision, project administration. J.X. and X.T.: data curation. J.X., Y.L., and X.T.: writing – original draft. Y.L.: visualization.

We confirm that informed consent has been obtained from the patient for the publication of their information and imaging data.

The authors declare no conflicts of interest.

内镜下粘膜剥离术(ESD)是一种成熟的食管肿瘤切除技术。然而,由于粘膜下层薄、食管运动性和可操作性有限等因素,ESD仍然具有挑战性。此外,单个内窥镜不能同时进行牵引,这促使了新型牵引技术的发展,以降低手术风险和整体切除率[1-4]。在这种情况下,我们开发了一种新的四点内牵引方法(视频S1)。60岁男性浅表性食管肿瘤行ESD手术。用双刀沿病变外缘划出0.5 cm的边缘,然后在粘膜下层注射亚甲基蓝透明质酸钠盐溶液以抬起病变。沿斑纹解剖粘膜及粘膜下层。一根橡皮筋系在第一个内夹上,一根棉线系在橡皮筋上。将内夹和棉线固定在病变肛侧,棉线的另一端留在外侧,以控制橡皮筋和随后的内夹放置。用橡皮筋进行外部牵引,可以放置第二个内夹,然后固定第三和第四内夹。橡皮筋回缩导致病变边缘向上和向内卷曲,完全暴露粘膜下层(图1)。通过多次粘膜下注射,病变被完全剥离。3.2 × 2.8 × 0.3 cm病灶在35分钟内全部切除,患者预后良好。操作原理图如图2所示。4点牵引方法有助于ESD,特别是对于常规牵引失败的较大病变。虽然使用了更多的夹子,但大大缩短了手术时间,提高了安全性和效率,尽管材料成本略高。橡皮筋的固定弹性使这种方法适用于大约2-4厘米x.t的病变。:概念,方法,写作-审查和编辑,监督,项目管理。J.X.和x.t.:数据管理。J.X, Y.L,和X.T:写作-原稿。Y.L:可视化。我们确认已获得患者的知情同意,以公布其信息和成像数据。作者声明无利益冲突。
{"title":"Endoscopic Submucosal Dissection of a Superficial Esophageal Neoplasm by 4-Point Inner-Traction Method","authors":"Jia Xu,&nbsp;Yang Liao,&nbsp;Xiaowei Tang","doi":"10.1111/den.70045","DOIUrl":"10.1111/den.70045","url":null,"abstract":"<p>Endoscopic submucosal dissection (ESD) is a well-established technique for esophageal tumor removal. However, ESD remains challenging due to factors like thin submucosa, esophageal motility, and limited maneuverability. Additionally, a single endoscope cannot simultaneously perform the traction, prompting the development of novel traction techniques to reduce surgical risks and en-bloc resection rates [<span>1-4</span>]. In this case, we developed a new 4-point internal traction method (Video S1).</p><p>A 60-year-old man with superficial esophageal neoplasm underwent ESD. A dual knife was used to mark a 0.5-cm margin along the lesion's outer edge, followed by injection of a methylene blue hyaluronate sodium saline solution into the submucosa to lift the lesion. Mucosa and submucosa were dissected along markings. A rubber band was attached to the first endoclip, and a cotton thread was secured to the rubber band. The endoclip and cotton thread were fixed on the anal side of the lesion, with the other end of the cotton thread left outside to control the rubber band and subsequent endoclip placements. External traction with the rubber band allowed placement of the second endoclip across it, followed by securing the third and fourth endoclips. The rubber band retraction caused the lesion's edges to curl upwards and inwards, fully exposing the submucosa (Figure 1). With repeated submucosal injections, the lesion was completely dissected. The 3.2 × 2.8 × 0.3 cm lesion was entirely removed in about 35 min, and the patient experienced a favorable prognosis. The operation schematic is shown in Figure 2.</p><p>The 4-point traction method facilitates ESD, especially for larger lesions where conventional traction fails. Although more clips are used, procedure time is significantly reduced, improving safety and efficiency despite slightly higher material cost. The fixed elasticity of the rubber band makes this method ideal for lesions approximately 2–4 cm.</p><p>X.T.: conceptualization, methodology, writing – review and editing, supervision, project administration. J.X. and X.T.: data curation. J.X., Y.L., and X.T.: writing – original draft. Y.L.: visualization.</p><p>We confirm that informed consent has been obtained from the patient for the publication of their information and imaging data.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The One-Minute Triple Stretch Reduces Musculoskeletal Discomfort in Endoscopic Assistants: A Crossover Trial With Motion Analysis 一分钟三重拉伸减少内窥镜助手的肌肉骨骼不适:运动分析的交叉试验。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-13 DOI: 10.1111/den.70040
Mafu Tsunemi, Ippei Matsuzaki, Yasuki Hori, Kazuki Hayashi, Hazuki Tamada, Shota Yamada, Kazuki Matsuzaki, Kazuki Sakai, Michihiro Kamijima, Takeshi Ebara

Objectives

Musculoskeletal disorders (MSDs) among endoscopic assistants are a major occupational concern. While ergonomic interventions such as education and microbreaks have reduced MSDs in surgical settings, few studies have focused specifically on endoscopic assistants. This study evaluated the effectiveness of a brief stretching protocol, the one-minute triple stretch (OMTS), in reducing MSD symptoms and improving posture.

Methods

This crossover study of 10 endoscopic assistants from two hospitals used a repeated measures quasi-experimental design. Participants were alternately assigned to a control group (standard procedures) or intervention group (OMTS every 20 min). Musculoskeletal discomfort was assessed using the Numerical Rating Scale. Work performance was evaluated via two standardized scales, and posture was analyzed using a motion tracking system. Data were collected at baseline, mid-, and postprocedure.

Results

The OMTS significantly reduced left shoulder discomfort at 120 min (p = 0.02, Hedges' g = −0.79), exceeding the minimal clinically important difference (MCID = 1.5). Moderate, nonsignificant effects were observed in the neck and lower back. Neck flexion posture improved significantly in the OMTS group (p = 0.03, g = −0.54), exceeding the MCID (2.9°).

Conclusion

The OMTS appears to be a feasible ergonomic intervention that can reduce MSD symptoms in endoscopic assistants. Further multicenter studies are needed to confirm its effectiveness.

Trial Registration: The study was registered in the UMIN Clinical Trials Registry (Registration Number: UMIN000048799) on August 31, 2022

目的:内窥镜助理的肌肉骨骼疾病(MSDs)是一个主要的职业问题。虽然人体工程学干预措施,如教育和微休息已经减少了手术环境中的msd,但很少有研究专门关注内窥镜助手。本研究评估了一种简短的拉伸方案,即一分钟三次拉伸(OMTS)在减少MSD症状和改善姿势方面的有效性。方法:采用重复测量准实验设计,对来自两家医院的10名内镜助手进行交叉研究。参与者被交替分配到对照组(标准程序)或干预组(每20分钟进行一次OMTS)。使用数值评定量表评估肌肉骨骼不适。工作表现通过两种标准化量表进行评估,并使用运动跟踪系统分析姿势。在基线、中期和术后收集数据。结果:OMTS在120 min时显著减轻左肩不适(p = 0.02, Hedges' g = -0.79),超过最小临床重要差异(MCID = 1.5)。在颈部和下背部观察到中度、不显著的影响。OMTS组颈部屈曲姿态明显改善(p = 0.03, g = -0.54),超过MCID组(2.9°)。结论:OMTS似乎是一种可行的符合人体工程学的干预措施,可以减少内窥镜助手的MSD症状。需要进一步的多中心研究来证实其有效性。试验注册:该研究已于2022年8月31日在UMIN临床试验注册中心注册(注册号:UMIN000048799)。
{"title":"The One-Minute Triple Stretch Reduces Musculoskeletal Discomfort in Endoscopic Assistants: A Crossover Trial With Motion Analysis","authors":"Mafu Tsunemi,&nbsp;Ippei Matsuzaki,&nbsp;Yasuki Hori,&nbsp;Kazuki Hayashi,&nbsp;Hazuki Tamada,&nbsp;Shota Yamada,&nbsp;Kazuki Matsuzaki,&nbsp;Kazuki Sakai,&nbsp;Michihiro Kamijima,&nbsp;Takeshi Ebara","doi":"10.1111/den.70040","DOIUrl":"10.1111/den.70040","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Musculoskeletal disorders (MSDs) among endoscopic assistants are a major occupational concern. While ergonomic interventions such as education and microbreaks have reduced MSDs in surgical settings, few studies have focused specifically on endoscopic assistants. This study evaluated the effectiveness of a brief stretching protocol, the one-minute triple stretch (OMTS), in reducing MSD symptoms and improving posture.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This crossover study of 10 endoscopic assistants from two hospitals used a repeated measures quasi-experimental design. Participants were alternately assigned to a control group (standard procedures) or intervention group (OMTS every 20 min). Musculoskeletal discomfort was assessed using the Numerical Rating Scale. Work performance was evaluated via two standardized scales, and posture was analyzed using a motion tracking system. Data were collected at baseline, mid-, and postprocedure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The OMTS significantly reduced left shoulder discomfort at 120 min (<i>p</i> = 0.02, Hedges' <i>g</i> = −0.79), exceeding the minimal clinically important difference (MCID = 1.5). Moderate, nonsignificant effects were observed in the neck and lower back. Neck flexion posture improved significantly in the OMTS group (<i>p</i> = 0.03, <i>g</i> = −0.54), exceeding the MCID (2.9°).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The OMTS appears to be a feasible ergonomic intervention that can reduce MSD symptoms in endoscopic assistants. Further multicenter studies are needed to confirm its effectiveness.</p>\u0000 \u0000 <p><b>Trial Registration:</b> The study was registered in the UMIN Clinical Trials Registry (Registration Number: UMIN000048799) on August 31, 2022</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Power Pure-Cut Hot Snare Polypectomy for Intensive Downstaging in Familial Adenomatous Polyposis: Promise, Practicality, and Evidence Still Needed 低倍率纯切热陷阱息肉切除术用于家族性腺瘤性息肉的强化降分期:前景、实用性和仍需证据。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-07 DOI: 10.1111/den.70046
Kazunori Takada
<p>Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary cancer syndrome accounting for roughly 1% of all colorectal cancers (CRCs). Compared with sporadic cancers, FAP is characterized by extreme, multifocal carcinogenesis. In untreated patients, the cumulative risk of CRC approaches 100% by a median age of 35–45 years [<span>1-3</span>] Current guidelines recommend initiating colonoscopic surveillance at ages 10–14 years to gauge polyp burden and determine the timing of prophylactic colectomy. Yet optimal management remains challenging. Recommended surveillance intervals, indications for prophylactic colectomy, and surgical choices differ across guidelines, reflecting imprecise estimates of the risks and benefits of competing interventions.</p><p>Proctocolectomy with ileal pouch–anal anastomosis (IPAA) has increasingly been selected as the standard prophylactic operation [<span>4</span>]. While IPAA offers substantial cancer prevention and preserves continence, it is technically complex and can result in postoperative anorectal dysfunction. Abdominal surgery itself carries a risk of intra-abdominal desmoid tumor formation; in women, IPAA may reduce fertility [<span>5</span>]. Moreover, the timing of prophylactic surgery should be individualized, taking into account social circumstances, family planning, emotional development, and the likelihood of reliable surveillance adherence [<span>1</span>]. For these reasons, prophylactic colectomy, although effective, is not universally ideal.</p><p>Against this background, intensive downstaging polypectomy (IDP)—actively resecting numerous adenomas to downstage polyp burden in patients with non-severe FAP—has emerged as a promising alternative enabled by advances in endoscopic technique. In a multicenter prospective study, IDP avoided colectomy in more than 90% of patients at 5 years [<span>6</span>]. Long-term oncologic outcomes remain limited, but IDP may help avoid or delay colectomy in carefully selected patients.</p><p>The method of resection during IDP is central to safety. In the initial IDP experience, hot snare polypectomy (HSP) with a bipolar snare was commonly used to reduce immediate bleeding and maintain a clear field while hundreds of polyps were resected [<span>6</span>] However, electrocautery can transmit thermal injury to deeper tissue planes, including larger vessels, raising the risk of delayed bleeding or perforation. When hundreds of diminutive and small lesions are removed in a single session, even low per-polyp risks can accumulate to clinically meaningful rates. A resection approach with a more favorable safety profile is therefore desirable.</p><p>Recent studies have evaluated low-power pure-cut hot snare polypectomy (LPPC HSP) for colorectal polyps up to 14 mm [<span>7-9</span>]. By eliminating coagulation current—which typically uses higher voltage—LPPC HSP aims to reduce deep thermal injury. In an experimental study, low-power pure-cut resections limited b
至于IDP中的LPPC HSP,目前的报告表明,尽管理论上存在与纯切割电流相关的术中渗出风险,但LPPC HSP可以保持手术效率。当在一次手术中切除数百个病变时,效率很重要;它影响手术时间、安全切除的病变数量、内窥镜医师疲劳和患者负担。在目前的队列中,息肉切除术的效率与双极陷阱入路相当,这表明术中出血不会严重干扰工作流程。在12例患者中,有20个病变发生了需要止血的出血,但每息肉发生迟发性出血、需要止血的出血和穿孔的发生率均极低,为0.015%(1/6581),支持了整体手术的效率和安全性。除了效率之外,LPPC HSP还可以实现精心管理的“废弃”策略。在LPPC HSP队列中,大部分切除的息肉在没有组织学的情况下被丢弃。先前的研究表明,使用LPPC HSP切除的10-14 mm腺瘤通常包括粘膜下层,并且获得了很高的完全切除率[7],这可能降低了在严格的标准下使用丢弃时遗漏侵袭性疾病的风险。在FAP背景下,腺瘤负担高,对每个病变进行组织学评估是不切实际的,lppc HSP可以支持精心实施的丢弃途径,同时对任何具有晚期特征或光学可疑的病变保持明确的例外。重要的限制应该缓和解释。IDP作为一个范例,主要的限制仍然是缺乏长期的肿瘤学数据:无论是重复疗程的累积不良事件,还是几十年来真正的癌症预防效果,都没有得到充分的描述。前瞻性、纵向研究对于确定IDP是否长期保持安全性和有效性至关重要。特别是对于LPPC HSP,相对于传统双极HSP或冷圈套息肉切除术(CSP)的相对安全性和定位仍然存在不确定性。虽然每个息肉穿孔率非常低(0.015%),但每个患者穿孔率为3.0%,这在预防性设置中并不微不足道。考虑到样本大小和非并发对照组,LPPC HSP是否比传统HSP更安全仍不确定。需要务实的、充分有力的比较——最好是多中心的比较——来确定延迟出血、穿孔、息肉切除术后综合征和计划外住院的相对风险。技术选择也很重要:IDP中大多数靶向腺瘤为10mm, CSP通常被认为比电切更安全,穿孔风险可以忽略不计。尽管CSP术中出血可能会更频繁,并且可能会减慢大容量手术的速度,但总的来说,对于大多数小型和小病变,CSP可能更有利,而LPPC HSP则保留在其效率大于风险的病变(例如,在10 - 14mm范围内或特定部位和形态)。确定什么时候(如果有的话)需要电灼治疗IDP应该是比较有效性研究的优先事项。最后,通用性和可实施性值得注意。IDP通常需要在大约一个小时内切除数百个息肉,这需要仔细的患者选择,细致的计划和高水平的手术技巧。由于穿孔确实发生在LPPC HSP队列中,IDP应在具有先进内镜治疗和遗传性结直肠癌综合征多学科护理经验的中心进行;专门的培训、团队工作流程、设备可用性和术后监测协议对于安全采用至关重要。总之,Tani等人提供了LPPC HSP作为IDP内FAP切除方法的重要前瞻性数据。IDP为选定的患者提供了推迟手术的途径,LPPC HSP可以通过保持效率和在严格的保障下允许丢弃来支持这一途径;然而,持久的肿瘤效益和相对安全性,特别是针对亚厘米病变的CSP,仍然需要在专家中心进行更大规模、更长期的研究来证明。高田和则撰写了手稿并批准了最终版本。作者没有什么可报道的。作者声明没有利益冲突。Tani, S. Shichijo, Y. Fujimoto等。家族性腺瘤性息肉患者低倍率纯切热陷阱息肉切除术的安全性和可行性。https://doi.org/10.1111/den.70009
{"title":"Low-Power Pure-Cut Hot Snare Polypectomy for Intensive Downstaging in Familial Adenomatous Polyposis: Promise, Practicality, and Evidence Still Needed","authors":"Kazunori Takada","doi":"10.1111/den.70046","DOIUrl":"10.1111/den.70046","url":null,"abstract":"&lt;p&gt;Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary cancer syndrome accounting for roughly 1% of all colorectal cancers (CRCs). Compared with sporadic cancers, FAP is characterized by extreme, multifocal carcinogenesis. In untreated patients, the cumulative risk of CRC approaches 100% by a median age of 35–45 years [&lt;span&gt;1-3&lt;/span&gt;] Current guidelines recommend initiating colonoscopic surveillance at ages 10–14 years to gauge polyp burden and determine the timing of prophylactic colectomy. Yet optimal management remains challenging. Recommended surveillance intervals, indications for prophylactic colectomy, and surgical choices differ across guidelines, reflecting imprecise estimates of the risks and benefits of competing interventions.&lt;/p&gt;&lt;p&gt;Proctocolectomy with ileal pouch–anal anastomosis (IPAA) has increasingly been selected as the standard prophylactic operation [&lt;span&gt;4&lt;/span&gt;]. While IPAA offers substantial cancer prevention and preserves continence, it is technically complex and can result in postoperative anorectal dysfunction. Abdominal surgery itself carries a risk of intra-abdominal desmoid tumor formation; in women, IPAA may reduce fertility [&lt;span&gt;5&lt;/span&gt;]. Moreover, the timing of prophylactic surgery should be individualized, taking into account social circumstances, family planning, emotional development, and the likelihood of reliable surveillance adherence [&lt;span&gt;1&lt;/span&gt;]. For these reasons, prophylactic colectomy, although effective, is not universally ideal.&lt;/p&gt;&lt;p&gt;Against this background, intensive downstaging polypectomy (IDP)—actively resecting numerous adenomas to downstage polyp burden in patients with non-severe FAP—has emerged as a promising alternative enabled by advances in endoscopic technique. In a multicenter prospective study, IDP avoided colectomy in more than 90% of patients at 5 years [&lt;span&gt;6&lt;/span&gt;]. Long-term oncologic outcomes remain limited, but IDP may help avoid or delay colectomy in carefully selected patients.&lt;/p&gt;&lt;p&gt;The method of resection during IDP is central to safety. In the initial IDP experience, hot snare polypectomy (HSP) with a bipolar snare was commonly used to reduce immediate bleeding and maintain a clear field while hundreds of polyps were resected [&lt;span&gt;6&lt;/span&gt;] However, electrocautery can transmit thermal injury to deeper tissue planes, including larger vessels, raising the risk of delayed bleeding or perforation. When hundreds of diminutive and small lesions are removed in a single session, even low per-polyp risks can accumulate to clinically meaningful rates. A resection approach with a more favorable safety profile is therefore desirable.&lt;/p&gt;&lt;p&gt;Recent studies have evaluated low-power pure-cut hot snare polypectomy (LPPC HSP) for colorectal polyps up to 14 mm [&lt;span&gt;7-9&lt;/span&gt;]. By eliminating coagulation current—which typically uses higher voltage—LPPC HSP aims to reduce deep thermal injury. In an experimental study, low-power pure-cut resections limited b","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Peroral Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Neoplasm 经口胰镜检查在导管内乳头状粘液瘤诊断中的意义。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-04 DOI: 10.1111/den.70044
Toshifumi Kin
<p>Intraductal papillary mucinous neoplasms (IPMNs) are well-known pancreatic cystic lesions characterized by the intraductal proliferation of mucin-producing epithelial cells within the pancreatic duct [<span>1, 2</span>]. Surgical resection is sometimes required for appropriate management of IPMN, and various reports and guidelines have proposed criteria for operative intervention [<span>3, 4</span>].</p><p>In the surgical management of IPMNs, accurate determination of the resection line is critical to achieving complete tumor resection with negative margins, thereby reducing the recurrence risk. Preoperative evaluation of the tumor extent is indispensable for selecting the appropriate surgical procedure. This assessment is straightforward in branch duct-type IPMNs without main pancreatic duct (MPD) dilation, as lesions are usually confined to the dilated pancreatic ducts. However, in IPMNs with MPD dilation—referred to as mixed-type IPMNs (MX-IPMNs)—the preoperative delineation of tumor spread is often challenging because it is difficult to estimate the longitudinal extent of the IPMN along the MPD. To date, various imaging modalities, including intraductal ultrasonography and endoscopic ultrasound, have been used to evaluate MPD involvement [<span>5-7</span>]. Peroral pancreatoscopy (POPS) is one such technique; however, its application has been limited due to high technical demands.</p><p>Recently, a disposable digital POPS (SpyGlass DS; Boston Scientific, Natick, MA, United States) has become available. This scope is easier to manipulate than the previous POPS (CHF-B260, Olympus Marketing, Tokyo, Japan), and many reports regarding the application of POPS in pancreatic disease have been published [<span>8, 9</span>]. In an issue of Digestive Endoscopy, Takahashi et al. investigated the frequency of MPD involvement in MX-IPMNs and evaluated the diagnostic ability of POPS to detect such involvement [<span>10</span>]. This study was conducted at a tertiary referral institution in Japan between July 2018 and December 2021 and included 15 patients who underwent surgical resection after POPS surveillance. MPD involvement was observed in 67% of cases with MX-IPMN, and among these, 70% were diagnosed with malignant IPMN, indicating high-grade dysplasia or invasive carcinoma based on resected specimens. The reported accuracy, sensitivity, and specificity of POPS for detecting MPD involvement in MX-IPMN were 93%, 90%, and 100%, respectively. Moreover, POPS demonstrated better diagnostic performance than computed tomography (CT), magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasonography (EUS).</p><p>A notable feature of this study was the frequent observation of malignant IPMNs among MX-IPMNs with MPD involvement. In other words, the presence of MPD involvement in MX-IPMN may serve as a significant indicator of malignancy. In Japan, tissue sampling from pancreatic cysts using EUS is generally discouraged due to the potential ri
导管内乳头状粘液瘤(IPMNs)是一种众所周知的胰腺囊性病变,其特征是胰腺导管内产生黏液的上皮细胞在导管内增殖[1,2]。为了对IPMN进行适当的治疗,有时需要手术切除,各种报告和指南都提出了手术干预的标准[3,4]。在IPMNs的手术治疗中,准确确定切除线对于实现阴性切缘的肿瘤完全切除,从而降低复发风险至关重要。术前评估肿瘤范围对选择合适的手术方式是必不可少的。在没有主胰管扩张的支管型IPMNs中,这种评估是直接的,因为病变通常局限于扩张的胰管。然而,在伴有MPD扩张的IPMN中——被称为混合型IPMN (mx -IPMN)——由于很难估计IPMN沿MPD的纵向范围,因此术前肿瘤扩散的描绘通常具有挑战性。迄今为止,各种成像方式,包括导管内超声检查和内镜超声检查,已被用于评估MPD的累及[5-7]。经口胰镜检查(POPS)就是这样一种技术;然而,由于技术要求高,其应用受到限制。最近,一种一次性数字持久性有机污染物(SpyGlass DS; Boston Scientific, Natick, MA, United States)已经上市。这个范围比以前的POPS (CHF-B260, Olympus Marketing, Tokyo, Japan)更容易操作,并且已经发表了许多关于POPS在胰腺疾病中的应用的报告[8,9]。在一期《消化道内窥镜》杂志上,Takahashi等人研究了MPD在MX-IPMNs中受诊的频率,并评估了持久性有机污染物检测这种受诊的诊断能力[10]。该研究于2018年7月至2021年12月在日本的一家三级转诊机构进行,包括15名在持久性有机污染物监测后接受手术切除的患者。67%的MX-IPMN患者有MPD累及,其中70%诊断为恶性IPMN,切除标本显示为高级别非典型增生或浸润性癌。据报道,持久性有机污染物检测MPD在MX-IPMN中的准确性、灵敏度和特异性分别为93%、90%和100%。此外,与计算机断层扫描(CT)、磁共振胰胆管造影(MRCP)和超声内镜(EUS)相比,POPS具有更好的诊断性能。本研究的一个显著特征是在伴有MPD的MX-IPMNs中经常观察到恶性IPMNs。换句话说,MPD参与MX-IPMN可能是恶性肿瘤的重要指标。在日本,由于潜在的肿瘤细胞播散风险,通常不鼓励使用EUS对胰腺囊肿进行组织取样,这限制了术前病理评估的可行性。因此,IPMNs的组织学分级通常只有在手术切除后才能确定。尽管如此,评估MPD的受累程度对于区分良性和恶性IPMNs以及估计肿瘤的范围可能是有价值的。本研究的另一个值得注意的特点是将持久性有机污染物(POPS)在检测MPD累及MX-IPMN方面的诊断性能与其他成像方式(如CT、MRCP和EUS)进行比较。MPD参与IPMN通常是基于局部MPD扩张来怀疑的,这相对容易通过各种成像方式检测到。然而,MPD受累程度的精确评估仍然具有挑战性。壁结节的检测对于确认MPD是否受累至关重要,因为其他病变,如蛋白质塞或粘液块,有时在成像模式上可以模拟壁结节,这使得鉴别诊断具有挑战性。此外,MPD内的壁结节并不总是突出的,可能表现为细微的低乳头状突起,使其检测复杂化。因此,仔细检查MPD的内部是必不可少的。因此,持久性有机污染物与其他成像方式相比具有明显的优势。虽然持久性有机污染物的临床应用已经得到认可,但本研究证实了其在MPD内部评估方面的优越能力,这是一个非常有价值的贡献。本研究表明持久性有机污染物在MPD受累评估中的重要性,这是诊断MX-IPMN的重要发现。因此,持久性有机污染物是所有MX-IPMN患者的理想适应症。最近,一种范围直径为9-Fr的更薄的持久性有机污染物(eyeMax, Micro-Tech,南京,中国)被开发出来。内窥镜技术的不断进步使得持久性有机污染物在IPMN诊断和治疗中的应用成为可能。然而,持久性有机污染物在临床环境中的可行性有待进一步调查。 例如,允许执行持久性有机污染物的MPD扩张程度仍不清楚。虽然本研究中所有患者都成功接受了持久性有机污染物治疗,但样本量很小。此外,应避免在持久性有机污染物期间过度操作,因为这可能导致胰腺炎或穿孔等不良事件。因此,对于建立持久性有机污染物的安全标准,特别是在MPD水平方面,需要更多的多中心研究,涉及更多的患者群体。总之,MPD累及在MX-IPMN中很常见,尤其是在恶性IPMN中。持久性有机污染物目前是评价MPD对MX-IPMN的影响最合适的方法,在怀疑MPD对MX-IPMN的影响时应予以考虑。有必要进行进一步的研究,以评价持久性有机污染物的可行性,并确定其使用的明确和具体的指示。作者声明无利益冲突。混合型导管内乳头状黏液性肿瘤在影像学上显示胰腺主管病变的频率是多少?https://doi.org/10.1111/den.15051
{"title":"Significance of Peroral Pancreatoscopy in the Diagnosis of Intraductal Papillary Mucinous Neoplasm","authors":"Toshifumi Kin","doi":"10.1111/den.70044","DOIUrl":"10.1111/den.70044","url":null,"abstract":"&lt;p&gt;Intraductal papillary mucinous neoplasms (IPMNs) are well-known pancreatic cystic lesions characterized by the intraductal proliferation of mucin-producing epithelial cells within the pancreatic duct [&lt;span&gt;1, 2&lt;/span&gt;]. Surgical resection is sometimes required for appropriate management of IPMN, and various reports and guidelines have proposed criteria for operative intervention [&lt;span&gt;3, 4&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;In the surgical management of IPMNs, accurate determination of the resection line is critical to achieving complete tumor resection with negative margins, thereby reducing the recurrence risk. Preoperative evaluation of the tumor extent is indispensable for selecting the appropriate surgical procedure. This assessment is straightforward in branch duct-type IPMNs without main pancreatic duct (MPD) dilation, as lesions are usually confined to the dilated pancreatic ducts. However, in IPMNs with MPD dilation—referred to as mixed-type IPMNs (MX-IPMNs)—the preoperative delineation of tumor spread is often challenging because it is difficult to estimate the longitudinal extent of the IPMN along the MPD. To date, various imaging modalities, including intraductal ultrasonography and endoscopic ultrasound, have been used to evaluate MPD involvement [&lt;span&gt;5-7&lt;/span&gt;]. Peroral pancreatoscopy (POPS) is one such technique; however, its application has been limited due to high technical demands.&lt;/p&gt;&lt;p&gt;Recently, a disposable digital POPS (SpyGlass DS; Boston Scientific, Natick, MA, United States) has become available. This scope is easier to manipulate than the previous POPS (CHF-B260, Olympus Marketing, Tokyo, Japan), and many reports regarding the application of POPS in pancreatic disease have been published [&lt;span&gt;8, 9&lt;/span&gt;]. In an issue of Digestive Endoscopy, Takahashi et al. investigated the frequency of MPD involvement in MX-IPMNs and evaluated the diagnostic ability of POPS to detect such involvement [&lt;span&gt;10&lt;/span&gt;]. This study was conducted at a tertiary referral institution in Japan between July 2018 and December 2021 and included 15 patients who underwent surgical resection after POPS surveillance. MPD involvement was observed in 67% of cases with MX-IPMN, and among these, 70% were diagnosed with malignant IPMN, indicating high-grade dysplasia or invasive carcinoma based on resected specimens. The reported accuracy, sensitivity, and specificity of POPS for detecting MPD involvement in MX-IPMN were 93%, 90%, and 100%, respectively. Moreover, POPS demonstrated better diagnostic performance than computed tomography (CT), magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasonography (EUS).&lt;/p&gt;&lt;p&gt;A notable feature of this study was the frequent observation of malignant IPMNs among MX-IPMNs with MPD involvement. In other words, the presence of MPD involvement in MX-IPMN may serve as a significant indicator of malignancy. In Japan, tissue sampling from pancreatic cysts using EUS is generally discouraged due to the potential ri","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/den.70044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145226443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features of Invasive Gastric Cancer Developed After Helicobacter pylori Eradication During Regular Endoscopic Surveillance 定期内镜检查根除幽门螺杆菌后发生浸润性胃癌的临床特点。
IF 4.7 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-28 DOI: 10.1111/den.70043
Akiko Sasaki, Junko Fujisaki, Masaaki Kobayashi, Ken Namikawa, Yusuke Kumazawa, Shu Hoteya, Kotaro Shibagaki, Kenshi Yao, Mitsushige Sugimoto, Takashi Kawai, Seiichiro Abe, Hiroya Ueyama, Masaaki Kodama, Kazunari Murakami, Hajime Isomoto, Masanori Ito, Kyoichi Adachi, Ken Ohata, Takanori Yamada, Moriya Iwaizumi, Mototsugu Kato, Shin'ichi Miyamoto, Kazuyoshi Yagi, Takashi Yao, Daisuke Yoshimura, Naoki Miyazaki, Toshikazu Ushijima, Naomi Uemura

Objectives

Gastric cancer (GC) may be diagnosed after Helicobacter pylori eradication, sometimes with submucosal invasion; however, its clinical features on regular endoscopic surveillance remain unclear. This study evaluated invasive GC's characteristics after H. pylori eradication during regular endoscopic surveillance by comparing them with intramucosal cancers.

Methods

This retrospective multicenter study across 14 institutions between 2001 and 2022 evaluated patients with GC with submucosal or deeper invasion after surgical or endoscopic resection (invasive GC), compared to patients with intramucosal GC from high-volume facilities. GC depth was analyzed using logistic regression (patient and mucosal factors as covariates), with significant factors explored in a subanalysis.

Results

In total, 116 of 413 patients with invasive GC and 189 of 545 with intramucosal GC were eligible for analysis. Invasive GC exhibited the following characteristics: (1) GC was a more common reason for H. pylori eradication (adjusted odds ratio [OR] 2.67; 95% confidence interval [CI] 1.25–5.69); (2) the upper third of the stomach was the more common site (OR 2.63; 95% CI 1.41–5.30); and (3) map-like redness (MLR) could not be confirmed (OR 4.12; 95% CI 2.53–6.69). Subgroup analysis suggested that GC with less MLR occurred more often in younger females (p < 0.004), showed antral intestinal metaplasia (p < 0.001), and was common in undifferentiated or mixed-type GC (p < 0.001).

Conclusions

Characteristic findings of invasive GC during regular endoscopic surveillance after H. pylori eradication were associated with less MLR, along with H. pylori eradication due to GC and the upper gastric lesion locations.

目的:胃癌(GC)可在幽门螺杆菌根除后诊断,有时伴有粘膜下浸润;然而,常规内镜检查的临床特征尚不清楚。本研究通过与粘膜内癌的比较,评估了常规内镜监测中幽门螺杆菌根除后侵袭性胃癌的特征。方法:这项2001年至2022年间在14家机构进行的回顾性多中心研究评估了手术或内镜切除后粘膜下或更深浸润的胃癌患者(浸润性胃癌),与来自大容量设施的粘膜内胃癌患者进行了比较。采用logistic回归(患者和粘膜因素为协变量)分析GC深度,并在亚分析中探讨显著因素。结果:413例浸润性胃癌患者中有116例符合分析条件,545例粘膜内胃癌患者中有189例符合分析条件。侵袭性胃癌表现出以下特点:(1)胃癌是根除幽门螺杆菌的更常见原因(调整优势比[OR] 2.67; 95%可信区间[CI] 1.25-5.69);(2)胃的上三分之一是最常见的部位(OR 2.63; 95% CI 1.41 ~ 5.30);(3) map-like red (MLR)无法确认(OR 4.12; 95% CI 2.53-6.69)。亚组分析显示,年轻女性更容易发生MLR较小的胃癌(p)。结论:幽门螺杆菌根除后,常规内镜监测中有创性胃癌的特征性发现与MLR较小相关,同时幽门螺杆菌根除与胃癌和胃上部病变部位有关。
{"title":"Clinical Features of Invasive Gastric Cancer Developed After Helicobacter pylori Eradication During Regular Endoscopic Surveillance","authors":"Akiko Sasaki,&nbsp;Junko Fujisaki,&nbsp;Masaaki Kobayashi,&nbsp;Ken Namikawa,&nbsp;Yusuke Kumazawa,&nbsp;Shu Hoteya,&nbsp;Kotaro Shibagaki,&nbsp;Kenshi Yao,&nbsp;Mitsushige Sugimoto,&nbsp;Takashi Kawai,&nbsp;Seiichiro Abe,&nbsp;Hiroya Ueyama,&nbsp;Masaaki Kodama,&nbsp;Kazunari Murakami,&nbsp;Hajime Isomoto,&nbsp;Masanori Ito,&nbsp;Kyoichi Adachi,&nbsp;Ken Ohata,&nbsp;Takanori Yamada,&nbsp;Moriya Iwaizumi,&nbsp;Mototsugu Kato,&nbsp;Shin'ichi Miyamoto,&nbsp;Kazuyoshi Yagi,&nbsp;Takashi Yao,&nbsp;Daisuke Yoshimura,&nbsp;Naoki Miyazaki,&nbsp;Toshikazu Ushijima,&nbsp;Naomi Uemura","doi":"10.1111/den.70043","DOIUrl":"10.1111/den.70043","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Gastric cancer (GC) may be diagnosed after <i>Helicobacter pylori</i> eradication, sometimes with submucosal invasion; however, its clinical features on regular endoscopic surveillance remain unclear. This study evaluated invasive GC's characteristics after <i>H. pylori</i> eradication during regular endoscopic surveillance by comparing them with intramucosal cancers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective multicenter study across 14 institutions between 2001 and 2022 evaluated patients with GC with submucosal or deeper invasion after surgical or endoscopic resection (invasive GC), compared to patients with intramucosal GC from high-volume facilities. GC depth was analyzed using logistic regression (patient and mucosal factors as covariates), with significant factors explored in a subanalysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total, 116 of 413 patients with invasive GC and 189 of 545 with intramucosal GC were eligible for analysis. Invasive GC exhibited the following characteristics: (1) GC was a more common reason for <i>H. pylori</i> eradication (adjusted odds ratio [OR] 2.67; 95% confidence interval [CI] 1.25–5.69); (2) the upper third of the stomach was the more common site (OR 2.63; 95% CI 1.41–5.30); and (3) map-like redness (MLR) could not be confirmed (OR 4.12; 95% CI 2.53–6.69). Subgroup analysis suggested that GC with less MLR occurred more often in younger females (<i>p</i> &lt; 0.004), showed antral intestinal metaplasia (<i>p</i> &lt; 0.001), and was common in undifferentiated or mixed-type GC (<i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Characteristic findings of invasive GC during regular endoscopic surveillance after <i>H. pylori</i> eradication were associated with less MLR, along with <i>H. pylori</i> eradication due to GC and the upper gastric lesion locations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":159,"journal":{"name":"Digestive Endoscopy","volume":"38 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1